Skip to content
MedsAcross

Medicine

Moexipril 7.5 mg tablet

Moexipril · Oral
Available on requestPrescription onlyUS FDAGeneric name

Moexipril 7.5 mg tablet is a generic prescription medicine for oral use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store, tightly closed, at 20° to 25°C (68° to 77°F), excursions permitted to…

Key facts

Active ingredient (INN)
Moexipril
Brand
Sold under the generic name
Strength
7.5 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 1000 tablets, 90 tablets and 2 more
Manufacturers
Glenmark PharmaceuticalsIndiaChartwell RXTeva Pharmaceuticals
Origin register
US FDA, United States
Storage
Store, tightly closed, at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F). Protect from excessive moisture.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
C09AA13 Moexipril
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
8 May 2003
Identifiers
RxCUI 1299896, 1299897DailyMed set ID baac91ad-f8ee-4694-89f8-5c47a8eda39a, 5c24072c-9769-4cb5-b8da-bf814d21391d, 5d4078f3-b621-475f-a4e6-005de2e62b32NDC 68462-209, 62135-967, 0093-0017Application ANDA090416, ANDA077536, ANDA076204

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet, film coated in 1 bottle68462-209-01Glenmark PharmaceuticalsIndia31 December 2010
1000 tablet, film coated in 1 bottle68462-209-10Glenmark PharmaceuticalsIndia31 December 2010
90 tablet, film coated in 1 bottle68462-209-90Glenmark PharmaceuticalsIndia31 December 2010
90 tablet, film coated in 1 bottle62135-967-90Chartwell RX5 March 2025
100 tablet, film coated in 1 bottle0093-0017-01Teva Pharmaceuticals8 May 2003

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 19 April 1995Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Moexipril

Clinical summary

Moexipril is an angiotensin converting enzyme inhibitor indicated for treatment of patients with hypertension. It is available as tablets for oral use. MedsAcross supplies Moexipril for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Moexipril

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Moexipril 7.5 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.